{"acute myeloid leukaemia": 100.44, "acute myeloid leukaemia recurrent": 132.81, "adverse event": 2.07, "agranulocytosis": 3.9, "anaemia": 4.35, "autoimmune haemolytic anaemia": 38.55, "blood calcium decreased": 8.61, "blood lactate dehydrogenase increased": 7.97, "blood phosphorus increased": 86.29, "blood potassium increased": 7.59, "blood uric acid increased": 8.6, "bone marrow failure": 6.33, "bone marrow transplant": 48.88, "c-reactive protein increased": 2.41, "chronic lymphocytic leukaemia": 158.14, "chronic lymphocytic leukaemia recurrent": 145.24, "cytopenia": 69.63, "disease progression": 3.78, "febrile neutropenia": 30.13, "fungal infection": 5.41, "general physical health deterioration": 2.46, "haematotoxicity": 35.68, "haemoglobin decreased": 3.64, "haemolysis": 6.5, "haemolytic anaemia": 3.32, "hospitalisation": 2.03, "hypercalcaemia": 4.98, "immune thrombocytopenia": 2.49, "infection": 10.41, "intentional product use issue": 2.8, "laboratory test abnormal": 7.92, "leukocytosis": 3.59, "leukopenia": 3.65, "lymphocyte count decreased": 5.46, "mantle cell lymphoma": 67.69, "minimal residual disease": 368.72, "multiple organ dysfunction syndrome": 3.03, "myelodysplastic syndrome": 10.41, "myelosuppression": 18.8, "neutropenia": 24.52, "neutropenic sepsis": 15.81, "neutrophil count decreased": 6.33, "off label use": 11.09, "pancytopenia": 9.4, "plasma cell myeloma": 10.85, "platelet count decreased": 4.89, "pleural effusion": 2.8, "pneumonia": 3.51, "pneumonia fungal": 23.6, "product use complaint": 17.04, "richter's syndrome": 633.19, "sepsis": 5.84, "septic shock": 5.31, "splenomegaly": 10.72, "systemic mycosis": 174.78, "therapeutic product effect incomplete": 2.62, "thrombocytopenia": 9.01, "transplant": 40.2, "tumour lysis syndrome": 229.0, "unevaluable event": 7.85, "white blood cell count decreased": 3.64, "white blood cell count increased": 3.94}